Unichem's formulation manufacturing facility at Ghaziabad has received an Establishment Inspection Report (EIR) from USFDA indicating closure of inspection. The inspection was conducted by FDA in April 2018.

Shares of the company declined Rs 4.65, or 1.93%, to trade at Rs 235.75. The total volume of shares traded was 25,427 at the BSE (12.34 p.m., Tuesday).